Literature DB >> 15452391

Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm.

Craig S Vinch1, Jason Rashkin, Giridhar Logsetty, Dennis A Tighe, Jeffrey C Hill, Theo E Meyer, Lawrence S Rosenthal, Gerard P Aurigemma.   

Abstract

BACKGROUND: Brain natriuretic peptide (BNP) levels have been reported to fall following cardioversion of atrial fibrillation (AF). The mechanism for the fall in BNP has not been elucidated and the potential confounding effects of sedation have not been investigated. Sedation may alter BNP levels via its effects on loading conditions. Accordingly, we studied whether BNP levels change shortly after cardioversion and attempted to control for possible effects of sedation.
METHODS: BNP levels were obtained before and after cardioversion in patients with AF and in a control group of patients undergoing intravenous conscious sedation for transesophageal echocardiography.
RESULTS: BNP levels dropped (260 +/- 255 vs. 190 +/- 212 pg/ml, p < 0.05) 40 min after cardioversion, decreasing in 33 of 41 subjects who achieved sinus rhythm. By contrast, mean BNP did not fall in subjects in whom cardioversion was not successful. The change in BNP level was not related to the degree of change in heart rate. No control subject experienced a change in cardiac rhythm; BNP levels increased (195 +/- 407 vs. 238 +/- 458 pg/ml, p < 0.05) in 18/22 subjects after sedation. Baseline BNP levels were elevated in subjects with AF, and BNP levels were elevated in parallel with heart failure symptoms.
CONCLUSIONS: The rapid fall in BNP after cardioversion (1) may reflect prompt hemodynamic improvement associated with rhythm change and (2) does not appear to be due to the effects of sedation. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452391     DOI: 10.1159/000081009

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

1.  Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.

Authors:  Borut Jug; Miran Sebestjen; Miso Sabovic; Maja Pohar; Irena Keber
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Changes of Atrial Natriuretic Peptides after Defibrillation Threshold Testing Predicted Future Ventricular Arrhythmia Event.

Authors:  Po-Ching Chi; Jen-Yuan Kuo; Chun-Yen Chen; An-Mei Wang; Chung-Lieh Hung; Sheng-Hsiung Chang; Bing-Fu Shih; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

3.  Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation.

Authors:  Yuko Kato; Shinya Suzuki; Tokuhisa Uejima; Hiroaki Semba; Hiroto Kano; Shunsuke Matsuno; Hideaki Takai; Takayuki Otsuka; Yuji Oikawa; Kazuyuki Nagashima; Hajime Kirigaya; Koichi Sagara; Takashi Kunihara; Junji Yajima; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Heart Vessels       Date:  2016-08-22       Impact factor: 2.037

4.  B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation.

Authors:  Jingtian Li; Lexin Wang
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

5.  Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.

Authors:  D-I Shin; K Jaekel; Ph Schley; A Sause; M Müller; R Fueth; T Scheffold; H Guelker; M Horlitz
Journal:  Z Kardiol       Date:  2005-12

6.  Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Authors:  Jayasree Pillarisetti; Namratha Reddy; Mazda Biria; Kay Ryschon; Darbhamulla Nagarajan; Caroline Murray; Donita Atkins; Sudharani Bommana; Madhu Yeruva Reddy; Luigi DiBiase; Rhea Pimentel; Loren Berenbom; Buddhadeb Dawn; Andrea Natale; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2014-05-08       Impact factor: 1.900

7.  Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.

Authors:  Rolf Wachter; Rosine Lahno; Beatrice Haase; Mark Weber-Krüger; Joachim Seegers; Frank Edelmann; Janin Wohlfahrt; Götz Gelbrich; Anke Görlitz; Pawel Kermer; Dirk Vollmann; Gerd Hasenfuß; Klaus Gröschel; Raoul Stahrenberg
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

8.  Natriuretic peptides for the detection of paroxysmal atrial fibrillation.

Authors:  Joachim Seegers; Markus Zabel; Timo Grüter; Antje Ammermann; Mark Weber-Krüger; Frank Edelmann; Götz Gelbrich; Lutz Binder; Christoph Herrmann-Lingen; Klaus Gröschel; Gerd Hasenfuß; Nicolas Feltgen; Burkert Pieske; Rolf Wachter
Journal:  Open Heart       Date:  2015-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.